Effects of mineralocorticoid-receptor stimulation on risk taking behavior in young healthy men and women
Introduction
Stress, conceptualized as a threat to the physiological and psychological integrity of the organism, requires specific cognitive and behavioral adjustments. Situational affordances demand quick action to counter the threat and cope with the stressor(McEwen, 1998). For instance, acute stress has been shown to induce a shift from deliberate, goal-directed behavior towards habitual and intuitive behavior (Schwabe and Wolf, 2011), a shift that is reflected in the activation of different information processing systems (Margittai et al., 2015). Risk taking behavior as a process affected by stress has only recently received research attention. In general, exposure to an acute stressful situation increases the tendency for risk taking (Morgado et al., 2015, Starcke and Brand, 2012). However, experimental results regarding stress effects on risk taking are equivocal and affected by personality characteristics such as impulsivity and sensation seeking (Lejuez et al., 2002, Wise et al., 2014). Some studies report divergent effects for men and women (Lighthall et al., 2009, Lighthall et al., 2012, van den Bos et al., 2009) or gains and losses (Buckert et al., 2014, Pabst et al., 2013b, Porcelli and Delgado, 2009), with other studies finding no effects of stress at all (Haushofer et al., 2013).
Comparatively little research has been devoted to the underlying neuroendocrine mechanisms of stress effects on risk taking behavior. Following the short-lived activation of the catecholaminergic stress system, the glucocorticoid cortisol is secreted from the adrenals and becomes centrally active by crossing the blood-brain barrier. These two stress systems are the main physiological mechanisms for behavioral effects of stress. In an early study, van Honk et al. (2003) reported an influence of basal cortisol levels on punishment sensitivity and reward dependency in a risk taking task, with more disadvantageous choices for participants with low cortisol levels. Another study (Chumbley et al., 2014) that investigated basal cortisol levels (derived from hair samples) found a positive relationship between endogenous cortisol levels and aversion for losses. Pabst et al. (2013a) reported decreased risk taking when the decision task was performed 5 or 18 min after a psychosocial stressor – but an increase in a 28 min delay. This result was explained by the authors with differential effects of rapidly-acting catecholamines and delayed effects of cortisol. In a direct pharmacological design, the administration of exogenous cortisol (hydrocortisone) increased risky decision making in male participants (Putman et al., 2010). These findings support the role of the cortisol system in the stress-induced modulation of risk taking.
Cortisol can easily cross the blood–brain barrier and feeds back on the brain via two different receptor types: the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR), with the MR occurring both in the cell nucleus and the membrane. Unlike the permanently occupied nuclear MR, the membrane-bound MR plays an active role in the acute stress response (Vogel et al., 2016). While cortisol effects on the brain have traditionally been attributed to the activation of the GR complex, recent studies could demonstrate the significance of the MR for various psychological domains (de Kloet, 2014, Groeneweg et al., 2011, Ter Horst et al., 2012), with both receptor types promoting differential, and to some degree opposing functional processes (Hermans et al., 2014, Vogel et al., 2016). Activation of the MR can improve executive functions and memory performance (Hinkelmann et al., 2014, Otte et al., 2015, Schultebraucks et al., 2016a), while blockade of the MR impaired these processes (Cornelisse et al., 2011, Otte et al., 2007, Rimmele et al., 2013). Furthermore, the MR seems to be specifically involved in emotional processing and the appraisal of novel situations; these are functions that rely on anatomical structures such as the amygdala and the prefrontal cortex, that also underlie reward processing, outcome prediction and risk assessment (Gathmann et al., 2014, Maier et al., 2015, Porcelli et al., 2012). Accordingly, the stress induced shift towards a cognitively less demanding amygdala-based learning strategy is mediated by MR activation (Vogel et al., 2015). Specific MR haplotypes are linked to dispositional optimism (Klok et al., 2011), which can be conceived as high expectations regarding future outcomes (Carver and Scheier, 2014). Recent studies in rats that investigated time-dependent effects of corticosterone (the cortisol equivalent in rodents) on reward-based decision-making imply differential effects for MR- and GR-mediated processes (Koot et al., 2013, Koot et al., 2014).
These receptor-specific effects cannot be differentially assessed by hydrocortisone administration because hydrocortisone acts on both MR and GR. In this study we examined the specific effects of MR stimulation on risk taking. To this end, we administered fludrocortisone, a selective MR agonist, to healthy young men and women in a placebo controlled, double-blind, full-factorial design. Risk taking was assessed with the Balloon Analogue Risk Task (BART), an established measure of risk taking behavior that has previously been applied to investigate stress effects on risk taking (Lighthall et al., 2009, Lighthall et al., 2012, Mehta et al., 2015; Reynolds et al., 2013). Since previous studies could demonstrate sex differences in risk taking behavior, we included sex as a factor in our analysis.
We hypothesized that participants in the fludrocortisone condition would show increased risk taking when compared to participants in the placebo condition. Based on the generally stronger risk tolerance in men (Byrnes et al., 1999), we expected men to exhibit riskier decision making compared to women. Since conflicting results have been reported regarding sex specific effects of stress on risk taking (Starcke and Brand, 2012), our study remains exploratory with regard to an interaction between sex and our drug intervention.
Section snippets
Participants
In total, 80 (40 women, age 18–30 years, mean age = 23.9 ± 3.3) healthy participants completed the study. Participants were undergraduate students, recruited at the Humboldt University and Free University Berlin. They received a monetary compensation of 40€.
The sex ratio was balanced for each condition. One male participant had to be excluded because of technical difficulties.
Exclusion criteria were any neurological, psychiatric or psychological disorders, acute or persistent medical disease and
Demographic data
Participants in the treatment conditions (fludrocortisone vs. placebo) did not differ with regard to age, sex, BMI, smoking or hormonal contraception (see Table 1).
Questionnaire data
There was no significant difference between treatment groups for any of the three dimensions of the MDBF, the DOSPERT or the DMI-45 (p > 0.05) (see Table 2).
Salivary cortisol responses
We found a significant treatment × time interaction (F 4,284 = 9.71, p <0.001; ηp2 = 0.12). Post-hoc t-tests revealed a significant difference between treatment groups for the measurement
Discussion
In the current study, we investigated the effect of MR-receptor stimulation by fludrocortisone on risk taking behavior. Consistent with our hypothesis, we found increased risk taking in the fludrocortisone group, as compared to placebo. This finding is in line with the large number of previous studies that have investigated stress effects or effects of exogenous cortisol on risk taking (Morgado et al., 2015, Starcke and Brand, 2012). Riskier decision making after administration of exogenous
Conflict of interest
Christian Otte has received honoraria fees for lectures from Lundbeck and Servier and has received compensation as a member of the scientific advisory board from Lundbeck. Christian Eric Deuter, Katja Wingenfeld, Katharina Schultebrauks, Julian Hellmann-Regen, Dominique Piber report no conflict of interest.
Funding
No external funding.
Disclosure
Christian Otte has received honoraria fees for lectures from Lundbeck and Servier and has received compensation as a member of the scientific advisory board from Lundbeck. Christian Eric Deuter, Katja Wingenfeld, Katharina Schultebrauks, Julian Hellmann-Regen, Dominique Piber report no conflict of interest.
Contributors
Christian Eric Deuter: Statistical analysis, literature research, wrote the manuscript.
Katharina Schultebrauks: Data collection, statistical analysis, data management, recruitment of participants.
Katja Wingenfeld: Co-PI, study design, supervising statistics, literature research, supervising the manuscript.
Dominique Piber: Data collection, statistical analysis, data management, recruitment of participants.
Julian Hellmann-Regen: Analysis and interpretation of cortisol data.
Christian Otte: PI,
Acknowledgement
We would like to thank all participants who took part in this study.
References (83)
- et al.
Physiological activity and receptor binding of 9 alpha fluorohydrocortisone
Biochem. Biophys. Res. Commun.
(1977) - et al.
Risk taking differences on a behavioral task as a function of potential reward/loss magnitude and individual differences in impulsivity and sensation seeking
Pharmacol. Biochem. Behav.
(2009) - et al.
Decision-making impairments in patients with pathological gambling
Psychiatry Res.
(2005) - et al.
A meta-analytic review of the impact of intranasal oxytocin administration on cortisol concentrations during laboratory tasks: moderation by method and mental health
Psychoneuroendocrinology
(2014) - et al.
Dispositional optimism
Trends Cogn. Sci.
(2014) - et al.
Comparison of neural correlates of risk decision making between genders: an exploratory fNIRS study of the Balloon Analogue Risk Task (BART)
Neuroimage
(2012) - et al.
Does cortisol modulate emotion recognition and empathy?
Psychoneuroendocrinology
(2016) - et al.
Brief report: the interaction of impulsivity with risk-taking is associated with early alcohol use initiation
J. Adolesc.
(2014) - et al.
Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness
Front. Neuroendocrinol.
(2003) - et al.
Dynamic adaptation of large-scale brain networks in response to acute stressors
Trends Neurosci.
(2014)
Time-dependent effects of corticosterone on reward-based decision-making in a rodent model of the Iowa Gambling Task
Neuropharmacology
Evaluation of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-world risk-taking behaviours
J. Adolesc.
Acute stress impairs self-control in goal-directed choice by altering multiple functional connections within the brain's decision circuits
Neuron
Testosterone and cortisol jointly modulate risk-taking
Psychoneuroendocrinology
The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone
Life Sci.
Stress and decision making: a few minutes make all the difference
Behav. Brain Res.
Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients
Psychoneuroendocrinology
Neural correlates of voluntary and involuntary risk taking in the human brain: an fMRI Study of the Balloon Analog Risk Task (BART)
Neuroimage
Influence of social stress on risk-taking behavior in adolescents
J. Anxiety Disord.
Stress-induced modulation of instrumental behavior: from goal-directed to habitual control of action
Behav. Brain Res.
Decision making under stress: a selective review
Neurosci. Biobehav. Rev.
Stress or no stress: mineralocorticoid receptors in the forebrain regulate behavioral adaptation
Neurobiol. Learn. Mem.
Stress and decision-making in humans: performance is related to cortisol reactivity, albeit differently in men and women
Psychoneuroendocrinology
A stress-induced shift from trace to delay conditioning depends on the mineralocorticoid receptor
Biol. Psychiatry
Cognitive adaptation under stress: a case for the mineralocorticoid receptor
Trends Cogn. Sci.
Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder
Neurobiol. Learn. Mem.
Similar processes despite divergent behavior in two commonly used measures of risky decision making
J. Behav. Decis. Mak.
A domain-specific risk-taking (DOSPERT) scale for adult populations
Judgment Decis. Mak.
Decision-making impairments in patients with Parkinson's disease
Behav. Neurol.
Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions
Neuropsychology
Acute stress affects risk taking but not ambiguity aversion
Front. Neurosci.
The assessment of risky decision making: a factor analysis of performance on the Iowa Gambling Task, Balloon Analogue Risk Task, and Columbia Card Task
Psychol. Assess.
Gender differences in risk taking: a meta-analysis
Psychol. Bull.
Impaired decision making on the Balloon Analogue Risk Task as a result of long-term alcohol use
J. Clin. Exp. Neuropsychol.
Endogenous cortisol predicts decreased loss aversion in young men
Psychol. Sci.
Social and emotional decision-making following frontal lobe injury
Neurocase
A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory
Neuropsychopharmacology
From receptor balance to rational glucocorticoid therapy
Endocrinology
Is all risk bad? Young adult cigarette smokers fail to take adaptive risk in a laboratory decision-making test
Psychopharmacology (Berl.)
The impact of sex hormone concentrations on decision-making in females and males
Front. Neurosci.
Feeling good and taking a chance? Associations of hypomania risk with cognitive and behavioral risk taking
Cogn. Ther. Res.
Cited by (15)
Stress effects on memory retrieval of aversive and appetitive instrumental counterconditioning in men
2022, Neurobiology of Learning and MemoryCitation Excerpt :Taking the interactive effects of cortisol and dopamine into account, the STARS (Stress Triggers Additional Reward Salience) model (Mather and Lighthall, 2012) states that stress promotes reward-related and disrupts punishment-related behavior, leading to increased approach and impaired avoidance learning. Thus, according to the STARS model stress hormones should facilitate risky and disadvantageous decisions and this effect has been shown to be especially pronounced in men (Deuter et al., 2017). Consequently, increases in approach behavior in stressed men as evident in the current study might be related to dopamine-related increases in reward sensitivity at the cost of avoidance behavior (Frank and Claus, 2006; Starcke and Brand, 2016).
The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression – Lessons from primary aldosteronism
2020, Journal of Psychiatric ResearchCitation Excerpt :One possible explanation for this variability may be that sex hormones and contraceptives have an influence on the ARR (Pizzolo et al., 2010). MR function appears to be influenced by gender (Deuter et al., 2017; Ter Horst et al., 2012). This might suggest a direct influence of sex hormones and their variability on the MR.
Effects of hydrocortisone and yohimbine on decision-making under risk
2020, PsychoneuroendocrinologyMineralocorticoid receptor function and cognition in health and disease
2019, PsychoneuroendocrinologySleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression
2019, Journal of Psychiatric ResearchCitation Excerpt :Sex differences were also described in animal data by Ter Horst et al. (Ter Horst, Carobrez, van der Mark, de Kloet and Oitzl, 2012) who proposed the MR to be involved in female stress and anxiety related disorders by additional modification by female sex hormones. Support comes from Deuter et al., (2017) who report sex differences in decision making after stimulation of the MR (Deuter et al., 2017). These results support the relevance of gender specific studies and treatment strategies in depression and anxiety.
Influence of glucocorticoid and mineralocorticoid receptor stimulation on task switching
2019, Hormones and Behavior